Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Active not recruiting 3Unknown 1Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 9Burkitt Lymphoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Biphenotypic, Acute 3Smoldering Multiple Myeloma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Meningioma 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Immunoglobulin Light-chain Amyloidosis 1Hodgkin Disease 1Esophageal Neoplasms 1Down Syndrome 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

daratumumab 6Dexamethasone 6pomalidomide 4Bortezomib 4Focal Adhesion Protein-Tyrosine Kinases 3venetoclax 2Specimen Handling 2Cyclophosphamide 2Calcium Dobesilate 2talquetamab 1ixazomib 1idecabtagene vicleucel 1dexamethasone acetate 1dexamethasone 21-phosphate 1darlin protein, Dictyostelium 1belantamab mafodotin 1auricularum 1X-Rays 1Tissue Banks 1Stem Cell Transplantation 1Spectrometry, Fluorescence 1Positron-Emission Tomography 1Polymerase Chain Reaction 1Pharmaceutical Preparations 1Phantoms, Imaging 1Melphalan 1Magnetic Resonance Spectroscopy 1Hyaluronoglucosaminidase 1Biopsy 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Immunoglobulin Light-chain Amyloidosis × dexamethasone acetate × Clear all
NCT06022939 2026-05-06

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

SWOG Cancer Research Network

Phase 3 Recruiting
338 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡